.Welcome to this week's Chutes & Ladders, our summary of significant leadership hirings, firings ...
.After disclosing plans to attack the U.S. public markets less than a month ago, Zenas Biopharma and...
.Psyence Biomedical is actually paying for $500,000 in shares to get fellow psilocybin-based biotech...
.Five months after approving Power Therapeutics' Pivya as the very first brand new procedure for sim...
.Eli Lilly has actually sprung into an AI-enabled medication discovery bargain, partnering along wit...
.Lykos CEO as well as creator Amy Emerson is quiting, with main operating officer Michael Mullette m...
.Novartis is opening a brand-new frontier in its own partnership with Voyager Therapies, paying $15 ...
.On the heels of an FDA denial for its primary rival Novo Nordisk, Eli Lilly is actually picking up ...
.Just a couple of months after dosing the first patient in a phase 2 trial for newly detected gliobl...
.Eli Lilly's hunt for excessive weight aim ats has led it to the darker genome. The Big Pharma has a...